Economic damage of risk factors associated with morbidity and mortality from major chronic non-communicable diseases in Russia in 2016

Aim. To assess the socioeconomic damage of risk factors associated with morbidity and mortality from major chronic non-communicable diseases (CNCDs) in the Russian population in 2016.

Material and methods. The following RF were included in the analysis: smoking, alcohol abuse, high salt intake, insufficient consumption of vegetables and fruits, consumption of processed red meat, low physical activity, obesity, hypertension (HTN), which have a significant causal relationship with the major CNCDs: cardiovascular diseases (CVDs), type 2 diabetes, chronic obstructive pulmonary disease (COPD), cancer of 10 locations (lung, breast, cervix, ovary, prostate, kidney, stomach, liver, pancreas, colon). Based on the data on the RF prevalence in the Russian population by ESSE-RF study and relative risks by large studies, the population attributable risk for each CNCD was estimated. We used the data of the Federal State Statistics Service, annual forms of Federal Statistical Observation, as well as the results of the Government Guarantee Program for free medical care and the corresponding diagnosis-related groups for 2016. The direct costs of the healthcare system and economic losses due to morbidity and mortality from the major CNCDs associated with the considered RF are determined. The calculations were performed in Microsoft Excel 10.0.

Results. Indirect losses due to premature mortality prevail over direct costs of medical care and disability benefits in the economic damage structure of each RF. The largest damage of four major CNCDs was associated with HTN — 869,9 billion rubles, which is equivalent to 1,01% of gross domestic product (GDP). The next places were taken by obesity — 605,8 billion rubles (0,7% of GDP), smoking — 421,4 billion rubles (0,49% of GDP) and low physical activity — 273,0 billion rubles. (0,32% of GDP). The contribution of improper feeding (high salt intake, insufficient consumption of vegetables and fruits, consumption of processed red meat) amounted to 0,17% of GDP (145,3 billion rubles), 0,19% of GDP (160,9 billion rubles) and 0,10% of GDP (83,4 billion rubles), respectively. Alcohol abuse made the smallest contribution to CNCD-related damage — 82,5 billion rubles (0.1% of GDP). This is due to the low prevalence of alcohol abuse in the Russian population according to ESSE-RF study.

Conclusion. Assessment of the economic damage of CNCD RF allows determining the priority areas in healthcare and substantiating the effectiveness of CNCD preventive measures aimed at reducing the RF impact, and, consequently, the burden on the healthcare system and the national economy.

1. Bloom DE, Cafiero ET, Jane-Lopis E, et al. The Global Economic Burden of Non-Communicable Diseases. Geneva: World Economic Forum, 2011. http://www.weforum.org/EconomicsOfNCD (25 September 2019).

2. Global health risks: mortality and burden of disease attributable to selected major risks. WHO, 2015. ISBN: 978-92-4-156387-1.

3. Yusuf S, Joseph P, Rangarajan S. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet online. 2019. doi:10.1016/S0140-6736(19)32008-2.

4. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52. doi:10.1016/S0140-6736(04)17018-9.

5. Krueger H, Rasali D, Fong D. The Economic Burden of Risk Factors in British Columbia, 2015. http://www.bccdc.ca/pop-public-health/Documents/economic_burden_five_risk_factors_BC_2015.pdf. (11 September 2019).

6. Crosland P, Ananthapavan J, Davison J. The economic cost of preventable disease in Australia: a systematic review of estimates and methods. Aust NZ J Public Health. 2019;43:484-95. doi:10.1111/1753-6405.12925.

7. Dobbs R, Sawers S, Thompson F, et al. Overcoming obesity: An initial economic analysis. Executive summary. Discussion paper, 2014. http://www.mckinsey.com/mgi (11 September 2019).

8. Candari C, Cylus J, Nolte E. Assessing the economic costs of unhealthy diets and low physical activity. An evidence review and proposed framework Health Policy Series, Copenhagen (Denmark): European Observatory on Health Systems and Policies. 2017;47 ISBN: 9789289050425.

9. Maslennikova GYa, Oganov RG. Medical and socioeconomic damage caused by smoking in the Russian Federation: diseases of circulatory system. The Russian Journal of Preventive Medicine. 2011;14(3):19-27. (In Russ.)

10. Krysanova VS, Zhuravleva MV, Dralova OV, et al. The problem of obesity and overweight in the Russian Federation and its pharmacoeconomic assessment. Almanac of Clinical Medicine. 2015;1:36-41. (In Russ.)

11. https://cyberleninka.ru/article/n/problema-ozhireniya-i-izbytochnoy-massy-tela-v-rossiyskoy-federatsii-i-ee-farmakoekonomicheskaya-otsenka (28 Сентября 2019).

12. Balanova YuA, Kontsevaya AV, Myrzamatova AO, et al. Economic damage associated with excess salt intake of Russian people in 2016. Cardiovascular Therapy and Prevention. 2019;18(4):62-8. (In Russ.) doi:10.15829/1728-8800-2019-4-62-68.

13. Balanova YuA, Kontsevaya AV, Shalnova SA, et al. The prevalence of behavioral risk factors for cardiovascular diseases in the Russian population according to the results of the ESSE-RF study. Russian Journal of Preventive Medicine and Public Health. 2014;5:42-51. (In Russ.)

14. Karamnova NS, Shalnova SA, Deev AD, et al. The nature of the nutrition of the adult population according to the epidemiological study ESSE-RF. Cardiovascular Therapy and Prevention. 2018; 17(4):61 -6. (In Russ.) doi:1015829/1728-8800-2018-4-61-66.

15. Kontsevaya AV, Drapkina OM, Balanova YuA, et al. Economic Burden of Cardiovascular Diseases in the Russian Federation in 2016. Rational Pharmacotherapy in Cardiology. 2018;14(2):156-66. (In Russ.) doi:10.20996/1819-6446-2018-14-2-156-166

16. Dedov II, Kontsevaya AV, Shestakova MV, et al. Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation. Diabetes Mellit. 2016; 19(6):518-27. (In Russ.)

17. Kontsevaya AV, Mukaneeva DK, Balanova YuA, et al. Economic burden of respiratory diseases and chronic obstructive pulmonary disease in Russian Federation, 2016. Russian Pulmonology. 2019;29(2):159-66. (In Russ.) doi:10.18093/0869-0189-2019-29-2-159-166.

18. Brown K, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. British Journal of Cancer. 2018;118:1130-41. doi:10.1038/s41416-018-0029-6.

19. Pirani N, Khiavi F. Population Attributable Fraction for Cardiovascular Diseases Risk Factors in Selected Countries: A comparative study. Mater Sociomed. 2017 Mar;29(1):35-9. doi:10.5455/msm.2017.29.35-39.

20. Woolf SH. A closer look at the economic argument for disease prevention. JAMA. 2009;301(5):536-8.

21. Meier T, Senftleben K, Deumelandt P, et al. Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis. PLoS One. 2015;10(9):e0135990. Published 2015 Sep 9. doi:10.1371/journal.pone.0135990.

22. Krueger H, Koot J, Andres E. The economic benefits of fruit and vegetable consumption in Canada. Can J Public Health. 2017 Jun 16;108(2):e152-e161. doi:10.17269/cjph.108.5721.

23. Cadilhac D, Magnus A, Cumming T, et al. The Health and Economic Benefits of Reducing Disease Risk Factors. Melbourne (AUST): Deakin University; 2009. https://www.vichealth.vic.gov.au/~/media/ResourceCentre/PublicationsandResources/Knowledge/Research%20Report_FINAL_July09.ashx (20 September 2019).

24. Cadilhac DA, Magnus A, Sheppard L, et al. The societal benefits of reducing six behavioural risk factors: An economic modelling study from Australia. BMC Public Health. 2011;(11):483. doi:10.1186/1471-2458-11-483.